Ross is a partner in the Corporate Technology & Life Sciences team, based in our Cambridge office.

Ross is a lead partner within the firm's Tier 1-ranked Biotechnology practice in Cambridge. His practice involves helping life sciences and technology companies as they progress through their life cycle in all aspects of their growth, capital raising and international expansion. As a sector specialist, Ross focuses on biotech, medical devices and diagnostics within Life Sciences, and with the Tech sector supports companies operating in the capital intensive deep tech space, including quantum computing, artificial intelligence, advanced materials, as well as web3.

Ross has extensive experience of a variety of venture and growth financing, public capital raisings, mergers and acquisitions and general corporate advice. Ross was based out of San Francisco, CA in 2018 – 19 and as a result, he has a particular expertise in transactions with a transatlantic component.

CV ansehen CV ausblenden

Aktuelle News & Insights

Gesellschaftsrecht/ M&A & Kapitalmärkte

Advising Baseimmune on its £9 million funding round

22. März 2024

von Ross McNaughton und Oli Denne

Klicken Sie hier für Details
Gesellschaftsrecht/ M&A & Kapitalmärkte

Advising on Mission Zero Technologies on its £21.8 million Series A funding

20. März 2024

von Ross McNaughton und Oli Denne

Klicken Sie hier für Details
Life Sciences & Gesundheitswesen

Word on the street at the J.P. Morgan Healthcare Conference 2024

17. Januar 2024
In-depth analysis

von mehreren Autoren

Klicken Sie hier für Details
Life Sciences & Gesundheitswesen

Advising gene therapy company AlveoGene on its complex spinout and launch investment

23. Oktober 2023

von mehreren Autoren

Klicken Sie hier für Details

Meet me at

Alle Veranstaltungen und Webinare finden Sie auf unserer Event-Seite.